Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence

MLA

Katherine R. Singleton, et al. “Melanoma Therapeutic Strategies That Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.” Cell Reports, vol. 21, no. 10, Dec. 2017, pp. 2796–812. EBSCOhost, https://doi.org/10.1016/j.celrep.2017.11.022.

APA

Katherine R. Singleton, Lorin Crawford, Elizabeth Tsui, Haley E. Manchester, Ophelia Maertens, Xiaojing Liu, Maria V. Liberti, Anniefer N. Magpusao, Elizabeth M. Stein, Jennifer P. Tingley, Dennie T. Frederick, Genevieve M. Boland, Keith T. Flaherty, Shannon J. McCall, Clemens Krepler, Katrin Sproesser, Meenhard Herlyn, Drew J. Adams, Jason W. Locasale, … Kris C. Wood. (2017). Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence. Cell Reports, 21(10), 2796–2812. https://doi.org/10.1016/j.celrep.2017.11.022

Chicago

Katherine R. Singleton, Lorin Crawford, Elizabeth Tsui, Haley E. Manchester, Ophelia Maertens, Xiaojing Liu, Maria V. Liberti, et al. 2017. “Melanoma Therapeutic Strategies That Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.” Cell Reports 21 (10): 2796–2812. doi:10.1016/j.celrep.2017.11.022.